Results 221 to 230 of about 84,355 (327)

Extracorporeal photopheresis—New insights into an old procedure

Transfusion Medicine, EarlyView.
Abstract Background Extracorporeal photopheresis (ECP) is a safe immunomodulatory strategy that induces cell‐type selective apoptosis through photodynamic processes. Despite decades of use, the mechanisms underlying ECP remain largely unexplored, particularly in studies examining specific immune cell subsets in ex vivo setups.
Sabine Seiffert, Janine Kirchberg, Enrica Bach, Victoria Menger, Mandy Brückner, Ulrich Sack, Ulrike Köhl, Uwe Platzbecker, Andreas Boldt, Marco Herling, Vladan Vučinić   +10 more
wiley   +1 more source

Effect of E7777 Immunogenicity on Pharmacokinetics, Efficacy, and Safety in Adult Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma. [PDF]

Clin Transl Sci
Thway TM, Aluri J, Lalovic B, Ooi CE, Sauter N, Xing D, Czuczman M, Yasuda S.   +7 more
europepmc   +1 more source

Detection of clonal T-cell receptor γ chain gene rearrangements by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE) in archival specimens from patients with early cutaneous T-cell lymphoma: Correlation of histologic findings with PCR/DGGE

, 1998
Julide Tok, Matthias J. Szabolcs, David N. Silvers, Jingyao Zhong, Anne Y. Matsushima   +4 more
openalex   +1 more source

One versus two: How much does it matter? A single‐center retrospective study evaluating 1‐day extracorporeal photopheresis schedule for treating patients with chronic lung allograft rejection

Transfusion, EarlyView.
Abstract Background Several studies show that extracorporeal photopheresis (ECP) might benefit chronic lung allograft dysfunction (CLAD). A standard ECP cycle consists of two consecutive procedures regardless of the technique employed. Study Design and Methods Evaluation of ECP cycle (from two to one procedure) modification due to pandemic restrictions
Claudia Del Fante, Valentina Vertui, Catherine Klersy, Cristina Mortellaro, Domenica Federica Briganti, Letizia Corinna Morlacchi, Marianna Russo, Cesare Perotti, Federica Meloni   +8 more
wiley   +1 more source

Available questionnaires do not cover important aspects of quality of life of patients with cutaneous T-cell lymphoma: evaluation of the quality of life of Polish patients with cutaneous T-cell lymphoma. [PDF]

Postepy Dermatol Alergol
Giza A, Sokołowska-Wojdyło M, Ciepłuch H, Olszewska B, Nowicki RJ, Kołkowski K.   +5 more
europepmc   +1 more source

Lymphocyte Activation in Cutaneous T-Cell Lymphoma

, 1995
Gary S. Wood
openalex   +1 more source

Variable CD7 Expression on T Cells in the Leukemic Phase of Cutaneous T Cell Lymphoma (Sézary Syndrome) [PDF]

, 2001
Eric C. Vonderheid, Amy Kotecha, Christine M. Boselli, Robert D. Bigler, Stuart R. Lessin, Maria Grazia Bernengo, Marcia Polansky   +6 more
openalex   +1 more source

Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is one of the most prevalent haematological malignancies in both humans and dogs, characterised in both species by significant clinical heterogeneity and limited prognostic predictability. With the introduction of next‐generation sequencing (NGS) technologies in veterinary medicine over the past decade ...
Antonella Fanelli, Eugenio Mazzone, Diana Giannuzzi, Laura Marconato, Luca Aresu   +4 more
wiley   +1 more source

Neighborhood factors and the risk of cutaneous T-cell lymphoma: A systematic review. [PDF]

JAAD Int
Turk J, Khoury L, Beauchamp R, Netchiporouk E, Pehr K.   +4 more
europepmc   +1 more source

Malignant and Normal T Cells Show Random Use of T-Cell Receptor ∝ Chain Variable Regions in Patients with Cutaneous T-Cell Lymphoma

, 1995
Jack Longley, Lynda Tyrrell, Shu-Zhuang Lu, JoAnn Farrell, Tie-Gang Ding, Shuling Yan, Denver Sallee, Peter Heald, Carole L. Berger, Robert E. Tigelaar, Richard L. Edelson   +10 more
openalex   +1 more source